Necrotizing Fasciitis: A Predictable Burden in Rural Kenya.


Journal

World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 22 5 2020
medline: 10 2 2021
entrez: 22 5 2020
Statut: ppublish

Résumé

Necrotizing fasciitis (NF) is a devastating disease with substantial morbidity and mortality. Poor outcomes are attributed to delayed diagnosis and management. Tenwek Hospital, a teaching and referral center in rural Kenya, manages many cases despite variable resources. We aimed to understand the burden of NF. All patients with admission NF diagnosis who presented in 2017 were reviewed for demographics, investigations, treatment, and outcomes. The primary outcome was unfavorable outcome defined as in-hospital mortality or amputation. Secondary outcomes were discharge diagnosis of NF and cost. Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score was calculated. Logistic regression models were utilized to assess the impact of risk factors. Sixty-seven patients were identified with an average age of 49.2 (±21) years. Medical comorbidities were present in 48% and history of trauma in 58%. Discharge diagnosis of NF occurred in 61% (N = 41). Overall, mortality occurred in 10% (N = 7) of patients with an initial NF diagnosis. At discharge, patients without NF had favorable outcomes in 96% (N = 25) compared to 78% (N = 32) with NF (p = 0.043). Final NF diagnosis costs 122,098 Kenyan Shillings more (95% confidence interval 36,142-208,054) than non-NF diagnosis (p value = 0.006). Factors associated with unfavorable outcome include diabetes mellitus, any comorbidity, increased heart rate, fever, hyperglycemia, anemia, and discharge NF diagnosis. Increased LRINEC score was associated with discharge NF diagnosis (p = 0.0006) and unfavorable outcome (p = 0.0157). Patients with NF in rural Kenya experience delays to presentation, unfavorable outcomes, and substantial costs. Certain factors, including LRINEC score, help predict diagnosis and outcome.

Sections du résumé

BACKGROUND
Necrotizing fasciitis (NF) is a devastating disease with substantial morbidity and mortality. Poor outcomes are attributed to delayed diagnosis and management. Tenwek Hospital, a teaching and referral center in rural Kenya, manages many cases despite variable resources. We aimed to understand the burden of NF.
METHODS
All patients with admission NF diagnosis who presented in 2017 were reviewed for demographics, investigations, treatment, and outcomes. The primary outcome was unfavorable outcome defined as in-hospital mortality or amputation. Secondary outcomes were discharge diagnosis of NF and cost. Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score was calculated. Logistic regression models were utilized to assess the impact of risk factors.
RESULTS
Sixty-seven patients were identified with an average age of 49.2 (±21) years. Medical comorbidities were present in 48% and history of trauma in 58%. Discharge diagnosis of NF occurred in 61% (N = 41). Overall, mortality occurred in 10% (N = 7) of patients with an initial NF diagnosis. At discharge, patients without NF had favorable outcomes in 96% (N = 25) compared to 78% (N = 32) with NF (p = 0.043). Final NF diagnosis costs 122,098 Kenyan Shillings more (95% confidence interval 36,142-208,054) than non-NF diagnosis (p value = 0.006). Factors associated with unfavorable outcome include diabetes mellitus, any comorbidity, increased heart rate, fever, hyperglycemia, anemia, and discharge NF diagnosis. Increased LRINEC score was associated with discharge NF diagnosis (p = 0.0006) and unfavorable outcome (p = 0.0157).
CONCLUSIONS
Patients with NF in rural Kenya experience delays to presentation, unfavorable outcomes, and substantial costs. Certain factors, including LRINEC score, help predict diagnosis and outcome.

Identifiants

pubmed: 32435826
doi: 10.1007/s00268-020-05581-4
pii: 10.1007/s00268-020-05581-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2919-2926

Références

Stevens DL, Bryant AE (2017) Necrotizing soft-tissue infections. N Engl J Med 377:2253–2265
doi: 10.1056/NEJMra1600673
Wong C-H, Wang Y-S (2005) The diagnosis of necrotizing fasciitis. Curr Opin Infect Dis 18:101–106
doi: 10.1097/01.qco.0000160896.74492.ea
Sartelli M, Malangoni MA, May AK et al (2014) World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections. World J Emerg Surg 9:57. https://doi.org/10.1186/1749-7922-9-57
doi: 10.1186/1749-7922-9-57 pubmed: 25422671 pmcid: 4242587
Morgan M (2010) Diagnosis and management of necrotising fasciitis: a multiparametric approach. J Hosp Infect 75:249–257
doi: 10.1016/j.jhin.2010.01.028
Taviloglu K, Yanar H (2007) Necrotizing fasciitis: strategies for diagnosis and management. World J Emerg Surg 2:19. https://doi.org/10.1186/1749-7922-2-19
doi: 10.1186/1749-7922-2-19 pubmed: 17683625 pmcid: 1988793
Francis K, Lamaute H, Davis J et al (1993) Implications of risk factors in necrotizing fasciitis. Am Surg 59:304–308
pubmed: 8489099
Park K-H, Jung S-I, Jung Y-S et al (2009) Marine bacteria as a leading cause of necrotizing fasciitis in coastal areas of South Korea. Am J Trop Med Hyg 80:646–650
doi: 10.4269/ajtmh.2009.80.646
Rieger UM, Gugger CY, Farhadi J et al (2007) Prognostic factors in necrotizing fasciitis and myositis: analysis of 16 consecutive cases at a single institution in Switzerland. Ann Plast Surg 58:523–530
doi: 10.1097/01.sap.0000244978.27053.08
Goh T, Goh L, Ang C et al (2014) Early diagnosis of necrotizing fasciitis. Br J Surg 101:e119–e125
doi: 10.1002/bjs.9371
Elliott DC, Kufera JA, Myers RA (1996) Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg 224:672
doi: 10.1097/00000658-199611000-00011
Wong C-H, Khin L-W, Heng K-S et al (2004) The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 32:1535–1541
doi: 10.1097/01.CCM.0000129486.35458.7D
Wall DB, Klein SR, Black S et al (2000) A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection. J Am Coll Surg 191:227–231
doi: 10.1016/S1072-7515(00)00318-5
McHenry CR, Piotrowski JJ, Petrinic D et al (1995) Determinants of mortality for necrotizing soft-tissue infections. Ann Surg 221:558
doi: 10.1097/00000658-199505000-00013
El-Menyar A, Asim M, Mudali IN et al (2017) The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) scoring: the diagnostic and potential prognostic role. Scand J Trauma Resusc Emerg Med 25:28
doi: 10.1186/s13049-017-0359-z
Bilton BD, Zibari GB, McMillan RW et al (1998) Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study/discussion. Am Surg 64:397
pubmed: 9585771
van Stigt SF, de Vries J, Bijker JB et al (2016) Review of 58 patients with necrotizing fasciitis in the Netherlands. World J Emerg Surg 11:21. https://doi.org/10.1186/s13017-016-0080-7
doi: 10.1186/s13017-016-0080-7 pubmed: 27239222 pmcid: 4884415
Jabbour G, El-Menyar A, Peralta R et al (2016) Pattern and predictors of mortality in necrotizing fasciitis patients in a single tertiary hospital. World J Emerg Surg 11:40. https://doi.org/10.1186/s13017-016-0097-y
doi: 10.1186/s13017-016-0097-y pubmed: 27508002 pmcid: 4977757
Magala J, Makobore P, Makumbi T et al (2014) The clinical presentation and early outcomes of necrotizing fasciitis in a Ugandan Tertiary Hospital—a prospective study. BMC Res Notes 7:476
doi: 10.1186/1756-0500-7-476
Legbo JN, Shehu BB (2005) Necrotizing fasciitis: a comparative analysis of 56 cases. J Natl Med Assoc 97:1692
pubmed: 16396062 pmcid: 2640750
Sadasivan J, Maroju NK, Balasubramaniam A (2013) Necrotizing fasciitis. Indian J Plast Surg 46:472–478
doi: 10.4103/0970-0358.121978
Kao LS, Lew DF, Arab SN et al (2011) Local variations in the epidemiology, microbiology, and outcome of necrotizing soft-tissue infections: a multicenter study. Am J Surg 202:139–145
doi: 10.1016/j.amjsurg.2010.07.041
Khamnuan P, Chongruksut W, Jearwattanakanok K et al (2015) Necrotizing fasciitis: risk factors of mortality. Risk Manag Healthc Policy 8:1
pubmed: 25733938 pmcid: 4337692
Lieberman JA, Stansbury LG, Kufera JA et al (2018) Red blood cell transfusions and anemia on admission are associated with poor outcomes in necrotizing soft tissue infections. J Appl Lab Med 2017:025643
Chen P-C, Tsai S-H, Wang J-C et al (2019) An elevated glycemic gap predicts adverse outcomes in diabetic patients with necrotizing fasciitis. PLoS ONE 14:e0223126
doi: 10.1371/journal.pone.0223126

Auteurs

Joyce Lunar (J)

Department of Surgery, Tenwek Hospital, P.O. Box 39, Bomet, 20400, Kenya.

Sinkeet S Ranketi (SS)

Department of Surgery, Tenwek Hospital, P.O. Box 39, Bomet, 20400, Kenya.

Beverly Owino (B)

Department of Surgery, Tenwek Hospital, P.O. Box 39, Bomet, 20400, Kenya.

Mark Oloo (M)

Department of Surgery, Tenwek Hospital, P.O. Box 39, Bomet, 20400, Kenya.

Robert K Parker (RK)

Department of Surgery, Tenwek Hospital, P.O. Box 39, Bomet, 20400, Kenya. robert_k_parker@brown.edu.
Department of Surgery, Alpert Medical School of Brown University, Providence, RI, USA. robert_k_parker@brown.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH